Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy
Open Access
- 11 January 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 155
Abstract
The traditional perception of ribosomes as uniform molecular machines has been revolutionized by recent discoveries, revealing a complex landscape of ribosomal heterogeneity. Opposing the conventional belief in interchangeable ribosomal entities, emerging studies underscore the existence of specialized ribosomes, each possessing unique compositions and functions. Factors such as cellular and tissue specificity, developmental and physiological states, and external stimuli, including circadian rhythms, significantly influence ribosome compositions. For instance, muscle cells and neurons are characterized by distinct ribosomal protein sets and dynamic behaviors, respectively. Furthermore, alternative forms of ribosomal RNA (rRNAs) and their post-transcriptional modifications add another dimension to this heterogeneity. These variations, orchestrated by spatial, temporal, and conditional factors, enable the manifestation of a broad spectrum of specialized ribosomes, each tailored for potentially distinct functions. Such specialization not only impacts mRNA translation and gene expression but also holds significant implications for broader biological contexts, notably in the realm of cancer research. As the understanding of ribosomal diversity deepens, it also paves the way for exploring novel avenues in cellular function and offers a fresh perspective on the molecular intricacies of translation.Keywords
Funding Information
- Italian Association for Cancer Research (G21562, 28136)
This publication has 106 references indexed in Scilit:
- Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylationOncogene, 2011
- Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemiaBlood, 2011
- Deregulation of oncogene‐induced senescence and p53 translational control in X‐linked dyskeratosis congenitaThe EMBO Journal, 2010
- c-Myc and eIF4F Constitute a Feedforward Loop That Regulates Cell Growth: Implications for Anticancer TherapyCancer Research, 2009
- Homoharringtonine affects the JAK2‐STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cellsEuropean Journal of Haematology, 2008
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and TranslationCancer Research, 2008
- A structural understanding of the dynamic ribosome machineNature Reviews Molecular Cell Biology, 2008
- Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis CongenitaScience, 2006
- RNA Structure: Reading the RibosomeScience, 2005
- Many Ribosomal Protein Genes Are Cancer Genes in ZebrafishPLOS Biology, 2004